News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Koconis John
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/22/2023 |
4
| Koconis John (CEO & Chairman) has filed a Form 4 on Timber Pharmaceuticals, Inc.|
Txns:
| Granted 70,385 shares
@ $0 |
|
| 04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2022 |
4
| Koconis John (CEO & Chairman of the Board) has filed a Form 4 on Timber Pharmaceuticals, Inc.|
Txns:
| Granted 600,000 options to buy
@ $0.307, valued at
$184.2k
|
|
| 12/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/16/2021 |
4
| Koconis John (CEO & President) has filed a Form 4 on Timber Pharmaceuticals, Inc.|
Txns:
| Granted 890,000 options to buy
@ $0.8925, valued at
$794.3k
|
|
| 05/20/2020 |
4
| Koconis John (CEO) has filed a Form 4 on Timber Pharmaceuticals, Inc.|
Txns:
| Granted 209,646 options to buy
@ $0.01, valued at
$2.1k
|
|
| 05/20/2020 |
3
| Koconis John (CEO) has filed a Form 3 on Timber Pharmaceuticals, Inc. |
|
|